272 filings
Page 3 of 14
PRE 14A
xwll81srhl07zqthsp
21 Apr 23
Preliminary proxy
4:00pm
424B5
wxjhrguhvxgv
4 Apr 23
Prospectus supplement for primary offering
4:16pm
S-8
5u1xdlj
29 Mar 23
Registration of securities for employees
8:45am
S-8
5u4gyn4rs atrwoo06
29 Mar 23
Registration of securities for employees
8:39am
8-K
bbm2uo9683z 642hym6o
29 Mar 23
Synlogic Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Updates
6:34am
8-K
7xz4fha myxosk7
19 Jan 23
Other Events
8:30am
8-K
t875d8upltxn4l5
15 Dec 22
Synlogic Announces Achievement of Proof of Concept for SYNB8802 in Enteric Hyperoxaluria Based on Urinary Oxalate Lowering in Phase 1b Study
8:31am
8-K
htzly k9yw3
9 Dec 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:01pm
8-K
1kg4 2s3oj61b2z
30 Nov 22
Synlogic Announces SYNB1353 Achieves Proof of Mechanism for Treatment of Homocystinuria and Provides Business Update
4:20pm
8-K
0a2v0ha ui1b603fbd9
23 Nov 22
Entry into a Material Definitive Agreement
7:00am
8-K
hwizwotr
10 Nov 22
Synlogic Reports Third Quarter 2022 Financial Results and Provides Business Update
6:27am
8-K
ur2s 56ytg
18 Oct 22
Synlogic Announces Positive Top-Line Phase 2 Data for Phenylketonuria (PKU); SYNB1934 Advances to Phase 3
8:30am
8-K
4o39 t1tbey39os
6 Sep 22
Other Events
8:26am
8-K
fugsnvbqdwft12ugk
11 Aug 22
Synlogic Reports Second Quarter 2022 Financial Results and Provides Business Update
6:31am
8-K
tnobgmf
13 Jun 22
Submission of Matters to a Vote of Security Holders
4:06pm
8-K
n7v c53nt4fkl
12 May 22
Synlogic Reports First Quarter 2022 Financial Results and Provides Business Update
7:30am